FDA Approves New Medication for Schizophrenia.
FDA Approves New Medication for Schizophrenia, Bipolar Disorder: – FRIDAY, Sept. 18, 2015 – – A new antipsychotic drug to take care of schizophrenia and bipolar disorder in adults has been accepted by the U tadaciped.com .S. Food and Drug Administration. The drug, Vraylar , is usually a capsule taken once a full day. Schizophrenia and bipolar disorder can be disabling and will greatly hinder day-to-day activities, Dr. Mitchell Mathis, director of the division of psychiatry products in the FDA’s Center for Medication Evaluation and Study, said within an agency news release. It is important to have a variety of treatment plans available to individuals with mental illnesses so that treatment plans can be tailored to meet a patient’s individual needs, Mathis said. (more…)